2015 Spring CLU Highlights
ApoB in Risk Assessment and the Diagnosis and Treatment of the Atherogenic Dyslipoproteinemias
Allan D. Sniderman, MD
Allan D. Sniderman, MD presents his talk on ApoB in Risk Assessment and the Diagnosis and Treatment of the Atherogenic Dyslipoproteinemias.
Tags:
Inflammation, Risk Prediction, and the Prevention of ASCVD
Paul M. Ridker, MD
Paul M. Ridker, MD presents his talk on Inflammation, Risk Prediction, and the Prevention of ASCVD.
Tags:
Two Different Prevention Approaches Two Different Perspectives
Carl E. Orringer, MD, FNLA
Carl E. Orringer, MD, FNLA presents his talk on Two Different Prevention Approaches Two Different Perspectives.
Tags:
Clinical Management of Hypertriglyceridemia: State of the Art 2015
Eliot A. Brinton, MD, FNLA
Eliot A. Brinton, MD, FNLA presents his talk on Clinical Management of Hypertriglyceridemia: State of the Art 2015.
Tags: